UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 338

Sortiert nach

Disparities In Outcomes Among COVID-19 Patients In A Large Health Care System In California

Health affairs (Millwood, Va.), 2020-07, Vol.39 (7), p.1253-12

2020

Link zum Volltext

Verfügbarkeit prüfen

Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents

The New England journal of medicine, 2021-07, Vol.385 (3), p.239-250

2021

Link zum Volltext

Verfügbarkeit prüfen

Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults

Nature (London), 2020-10, Vol.586 (7830), p.589-593

2020

Link zum Volltext

Verfügbarkeit prüfen

Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

The New England journal of medicine, 2020-12, Vol.383 (25), p.2439-2450

2020

Link zum Volltext

Verfügbarkeit prüfen

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial

The Lancet (British edition), 2013-03, Vol.381 (9871), p.1021-1028

2013

Link zum Volltext

Verfügbarkeit prüfen

Epidemiology of Invasive Escherichia coli Infection and Antibiotic Resistance Status Among Patients Treated in US Hospitals: 2009–2016

Clinical infectious diseases, 2021-08, Vol.73 (4), p.565-574

2021

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of the BNT162b2 mRNA COVID-19 vaccine in participants with a history of cancer: subgroup analysis of a global phase 3 randomized clinical trial

Vaccine, 2022-03, Vol.40 (10), p.1483-1492

2022

Link zum Volltext

Verfügbarkeit prüfen

Serum Cortisol: An Up-To-Date Assessment of Routine Assay Performance

Clinical chemistry (Baltimore, Md.), 2016-09, Vol.62 (9), p.1220-1229

2016

Link zum Volltext

Verfügbarkeit prüfen

Bivalent Omicron BA.1–Adapted BNT162b2 Booster in Adults Older than 55 Years

The New England journal of medicine, 2023-01, Vol.388 (3), p.214-227

2023

Link zum Volltext

Verfügbarkeit prüfen

Phase 3 immunogenicity and safety study of a tick-borne encephalitis vaccine in healthy Japanese participants 1 year of age and older

Vaccine, 2024-04

2024

Link zum Volltext

Verfügbarkeit prüfen

Persistence of Disparities Among Racially/Ethnically Marginalized Groups in the Coronavirus Disease 2019 Pandemic Regardless of Statewide Shelter-in-Place Policies: An Analysis From Northern California

American journal of epidemiology, 2021-11, Vol.190 (11), p.2300-2313

2021

Link zum Volltext

Verfügbarkeit prüfen

A Phase 2 Extension Study Evaluating the Immunogenicity, Safety, and Tolerability of 3 or 4 Doses of a Clostridioides difficile Vaccine in Healthy US Adults Aged 65 to 85 Years

The Journal of infectious diseases, 2024-02, Vol.229 (2), p.367-375

2024

Link zum Volltext

Verfügbarkeit prüfen

A phase 3 study evaluating the lot consistency, immunogenicity, safety, and tolerability of a Clostridioides difficile vaccine in healthy adults 65 to 85 years of age

Vaccine, 2023-12, Vol.41 (50), p.7548-7559

2023

Link zum Volltext

Verfügbarkeit prüfen

A randomized study to evaluate safety and immunogenicity of the BNT162b2 COVID-19 vaccine in healthy Japanese adults

Nature communications, 2021-12, Vol.12 (1), p.7105-7105, Article 7105

2021

Link zum Volltext

Verfügbarkeit prüfen

Safety and immunogenicity of a multidose vial formulation of 13-valent pneumococcal conjugate vaccine administered with routine pediatric vaccines in healthy infants in India: A phase 4, randomized, open-label study

Vaccine, 2021-11, Vol.39 (46), p.6787-6795

2021

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of a Pneumococcal Conjugate Vaccine against Acute Otitis Media

The New England journal of medicine, 2001-02, Vol.344 (6), p.403-409

2001

Link zum Volltext

Verfügbarkeit prüfen

Safety and Immunogenicity of the BNT162b2 Vaccine Coadministered with Seasonal Inactivated Influenza Vaccine in Adults

Infectious diseases and therapy, 2023-09, Vol.12 (9), p.2241-2258

2023

Link zum Volltext

Verfügbarkeit prüfen

Using a Human Challenge Model of Infection to Measure Vaccine Efficacy: A Randomised, Controlled Trial Comparing the Typhoid Vaccines M01ZH09 with Placebo and Ty21a

PLoS neglected tropical diseases, 2016-08, Vol.10 (8), p.e0004926

2016

Link zum Volltext

Verfügbarkeit prüfen

Measuring and Promoting SARS-CoV-2 Vaccine Equity: Development of a COVID-19 Vaccine Equity Index

Health equity, 2021-07, Vol.5 (1), p.476-483

2021

Link zum Volltext

Verfügbarkeit prüfen

COVID-19 in pregnancy by race and ethnicity: Implications for development of a vaccination strategy

Women's health (London, England), 2021-12, Vol.17, p.17455065211063300-17455065211063300

2021

Link zum Volltext

Verfügbarkeit prüfen

Progress toward a universal H5N1 vaccine: a recombinant modified vaccinia virus Ankara-expressing trivalent hemagglutinin vaccine

PloS one, 2014-09, Vol.9 (9), p.e107316-e107316

2014

Link zum Volltext

Verfügbarkeit prüfen

Heat Inactivation of Saliva Samples for the Analysis of Cortisol and Cortisone during the COVID-19 Pandemic

The journal of applied laboratory medicine, 2020-11, Vol.5 (6), p.1413-1416

2020

Link zum Volltext

Verfügbarkeit prüfen

Phase 1 trial of a 13-valent pneumococcal conjugate vaccine in healthy adults

Vaccine, 2007-08, Vol.25 (33), p.6164-6166

2007

Link zum Volltext

Verfügbarkeit prüfen

Determination of tobramycin in serum using liquid chromatography–tandem mass spectrometry and comparison with a fluorescence polarisation assay

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2003-09, Vol.794 (2), p.329-335

2003

Link zum Volltext

Verfügbarkeit prüfen

Measuring Health Equity for Ambulatory Care Sensitive Conditions in a Large Integrated Health Care System: The Development of an Index

Health equity, 2019-01, Vol.3 (1), p.92-98

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 338

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(285)
Mit Volltextzugriff
(309)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(338)
Japanisch
(43)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Disparities In Outcomes Among COVID-19 Patients In A Large Health Care System In California

Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents

Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults

Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial

Epidemiology of Invasive Escherichia coli Infection and Antibiotic Resistance Status Among Patients Treated in US Hospitals: 2009–2016

Efficacy and safety of the BNT162b2 mRNA COVID-19 vaccine in participants with a history of cancer: subgroup analysis of a global phase 3 randomized clinical trial

Serum Cortisol: An Up-To-Date Assessment of Routine Assay Performance

Bivalent Omicron BA.1–Adapted BNT162b2 Booster in Adults Older than 55 Years

Phase 3 immunogenicity and safety study of a tick-borne encephalitis vaccine in healthy Japanese participants 1 year of age and older

Persistence of Disparities Among Racially/Ethnically Marginalized Groups in the Coronavirus Disease 2019 Pandemic Regardless of Statewide Shelter-in-Place Policies: An Analysis From Northern California

A Phase 2 Extension Study Evaluating the Immunogenicity, Safety, and Tolerability of 3 or 4 Doses of a Clostridioides difficile Vaccine in Healthy US Adults Aged 65 to 85 Years

A phase 3 study evaluating the lot consistency, immunogenicity, safety, and tolerability of a Clostridioides difficile vaccine in healthy adults 65 to 85 years of age

A randomized study to evaluate safety and immunogenicity of the BNT162b2 COVID-19 vaccine in healthy Japanese adults

Safety and immunogenicity of a multidose vial formulation of 13-valent pneumococcal conjugate vaccine administered with routine pediatric vaccines in healthy infants in India: A phase 4, randomized, open-label study

Efficacy of a Pneumococcal Conjugate Vaccine against Acute Otitis Media

Safety and Immunogenicity of the BNT162b2 Vaccine Coadministered with Seasonal Inactivated Influenza Vaccine in Adults

Using a Human Challenge Model of Infection to Measure Vaccine Efficacy: A Randomised, Controlled Trial Comparing the Typhoid Vaccines M01ZH09 with Placebo and Ty21a

Measuring and Promoting SARS-CoV-2 Vaccine Equity: Development of a COVID-19 Vaccine Equity Index

COVID-19 in pregnancy by race and ethnicity: Implications for development of a vaccination strategy

Progress toward a universal H5N1 vaccine: a recombinant modified vaccinia virus Ankara-expressing trivalent hemagglutinin vaccine

Heat Inactivation of Saliva Samples for the Analysis of Cortisol and Cortisone during the COVID-19 Pandemic

Phase 1 trial of a 13-valent pneumococcal conjugate vaccine in healthy adults

Determination of tobramycin in serum using liquid chromatography–tandem mass spectrometry and comparison with a fluorescence polarisation assay

Measuring Health Equity for Ambulatory Care Sensitive Conditions in a Large Integrated Health Care System: The Development of an Index

Suchergebnisse filtern